(Q43175293)
Statements
A randomized, open-label, 2-period, crossover bioequivalence study of two oral formulations of 75 mg oseltamivir in healthy Thai volunteers (English)
S Kongpatanakul
S Chatsiricharoenkul
U Panich
K Sathirakul
P Pongnarin